277 related articles for article (PubMed ID: 24710966)
1. Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?
Stomby A; Andrew R; Walker BR; Olsson T
Diabetologia; 2014 Jun; 57(6):1100-10. PubMed ID: 24710966
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue expression of 11beta-hydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity.
Espíndola-Antunes D; Kater CE
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1397-403. PubMed ID: 18209879
[TBL] [Abstract][Full Text] [Related]
3. Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
Tomlinson JW; Moore JS; Clark PM; Holder G; Shakespeare L; Stewart PM
J Clin Endocrinol Metab; 2004 Jun; 89(6):2711-6. PubMed ID: 15181046
[TBL] [Abstract][Full Text] [Related]
4. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
Walker BR
Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
[TBL] [Abstract][Full Text] [Related]
5. The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Stimson RH; Walker BR
Horm Mol Biol Clin Investig; 2013 Sep; 15(2):37-48. PubMed ID: 25436731
[TBL] [Abstract][Full Text] [Related]
6. Metformin Increases Cortisol Regeneration by 11βHSD1 in Obese Men With and Without Type 2 Diabetes Mellitus.
Anderson AJ; Andrew R; Homer NZ; Jones GC; Smith K; Livingstone DE; Walker BR; Stimson RH
J Clin Endocrinol Metab; 2016 Oct; 101(10):3787-3793. PubMed ID: 27459533
[TBL] [Abstract][Full Text] [Related]
7. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
Morton NM; Seckl JR
Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microsomal cortisol production by (-)-epigallocatechin-3-gallate through a redox shift in the endoplasmic reticulum--a potential new target for treating obesity-related diseases.
Szelényi P; Révész K; Konta L; Tüttõ A; Mandl J; Kereszturi É; Csala M
Biofactors; 2013; 39(5):534-41. PubMed ID: 23554216
[TBL] [Abstract][Full Text] [Related]
9. 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.
Stulnig TM; Waldhäusl W
Diabetologia; 2004 Jan; 47(1):1-11. PubMed ID: 14652720
[TBL] [Abstract][Full Text] [Related]
10. Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity.
Michailidou Z; Jensen MD; Dumesic DA; Chapman KE; Seckl JR; Walker BR; Morton NM
Obesity (Silver Spring); 2007 May; 15(5):1155-63. PubMed ID: 17495191
[TBL] [Abstract][Full Text] [Related]
11. Different expression and distribution of 11beta-hydroxysteroid dehydrogenase type 1 in obese and lean animal models of type 2 diabetes.
Czegle I; Margittai E; Senesi S; Benedetti A; Bánhegyi G
Acta Physiol Hung; 2008 Dec; 95(4):419-24. PubMed ID: 19009916
[TBL] [Abstract][Full Text] [Related]
12. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
Pereira CD; Azevedo I; Monteiro R; Martins MJ
Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity.
Wake DJ; Walker BR
Endocrine; 2006 Feb; 29(1):101-8. PubMed ID: 16622297
[TBL] [Abstract][Full Text] [Related]
14. 11β-Hydroxysteroid dehydrogenase activity in the brain does not contribute to systemic interconversion of cortisol and cortisone in healthy men.
Kilgour AH; Semple S; Marshall I; Andrews P; Andrew R; Walker BR
J Clin Endocrinol Metab; 2015 Feb; 100(2):483-9. PubMed ID: 25393644
[TBL] [Abstract][Full Text] [Related]
15. Obesity is accompanied by disturbances in peripheral glucocorticoid metabolism and changes in FA recycling.
Simonyte K; Rask E; Näslund I; Angelhed JE; Lönn L; Olsson T; Mattsson C
Obesity (Silver Spring); 2009 Nov; 17(11):1982-7. PubMed ID: 19360009
[TBL] [Abstract][Full Text] [Related]
16. Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes.
Gathercole LL; Stewart PM
J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):21-7. PubMed ID: 20347978
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase.
Bujalska IJ; Kumar S; Hewison M; Stewart PM
Endocrinology; 1999 Jul; 140(7):3188-96. PubMed ID: 10385414
[TBL] [Abstract][Full Text] [Related]
18. Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor.
Courtney R; Stewart PM; Toh M; Ndongo MN; Calle RA; Hirshberg B
J Clin Endocrinol Metab; 2008 Feb; 93(2):550-6. PubMed ID: 17986636
[TBL] [Abstract][Full Text] [Related]
19. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.
Nair S; Lee YH; Lindsay RS; Walker BR; Tataranni PA; Bogardus C; Baier LJ; Permana PA
Diabetologia; 2004 Jun; 47(6):1088-95. PubMed ID: 15156315
[TBL] [Abstract][Full Text] [Related]
20. Contribution of local regeneration of glucocorticoids to tissue steroid pools.
Khan S; Livingstone DEW; Zielinska A; Doig CL; Cobice DF; Esteves CL; Man JTY; Homer NZM; Seckl JR; MacKay CL; Webster SP; Lavery GG; Chapman KE; Walker BR; Andrew R
J Endocrinol; 2023 Sep; 258(3):. PubMed ID: 37343234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
